
Sign up to save your podcasts
Or


In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.
By Jeffrey S. Guy, MD, FACS4.8
649649 ratings
In this episode we talk about the results of the CRASH-2 trial published in Lancet. This trial showed that the EARLY use of Tranexamic acid may improve survivial, but delayed use may be associated with an increased mortality.

64,173 Listeners

11,432 Listeners

1,079 Listeners

1,225 Listeners

939 Listeners

3,851 Listeners

2,868 Listeners

1,549 Listeners

1,149 Listeners

8,375 Listeners

405 Listeners

998 Listeners